Normal Volunteers, Patients, or Hybrids? Should We Build the Bridge Slowly to Cross It Quickly?

Translational research in orphan disease drug development

Read more

This webinar will cover the following orphan drug topics: How to adjudicate multiple stakeholder perspectives in first-in-human studies with constrained resources; More dose levels, fewer participants, and the importance of bioanalysis.


Chief Medical and Scientific Officer
Chief Scientific Officer, Early Phase Development

Want to learn more about Worldwide Clinical Trials?